These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28585053)

  • 21. Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis.
    Rossini M; Viapiana O; Idolazzi L; Ghellere F; Fracassi E; Troplini S; Povino MR; Kunnathully V; Adami S; Gatti D
    Calcif Tissue Int; 2016 May; 98(5):438-45. PubMed ID: 26645432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of the relationship between serum sclerostin and dickkopf-1 protein levels with bone turnover in children and adolescents with type-1 diabetes mellitus.
    Kurban S; Selver Eklioglu B; Selver MB
    J Pediatr Endocrinol Metab; 2022 May; 35(5):673-679. PubMed ID: 35411762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sclerostin levels during growth in children.
    Kirmani S; Amin S; McCready LK; Atkinson EJ; Melton LJ; Müller R; Khosla S
    Osteoporos Int; 2012 Mar; 23(3):1123-30. PubMed ID: 21617991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women.
    Sheng Z; Tong D; Ou Y; Zhang H; Zhang Z; Li S; Zhou J; Zhang J; Liao E
    Clin Endocrinol (Oxf); 2012 Jun; 76(6):797-801. PubMed ID: 22151063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis.
    Wang A; Karunasinghe N; Plank LD; Zhu S; Osborne S; Brown C; Bishop K; Schwass T; Tijono S; Holmes M; Masters J; Huang R; Keven C; Ferguson LR; Lawrenson R
    Sci Rep; 2021 Jul; 11(1):14905. PubMed ID: 34290287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes of serum sclerostin and Dickkopf-1 levels during the menstrual cycle. A pilot study.
    Liakou CG; Mastorakos G; Makris K; Fatouros IG; Avloniti A; Marketos H; Antoniou JD; Galanos A; Dontas I; Rizos D; Tournis S
    Endocrine; 2016 Nov; 54(2):543-551. PubMed ID: 27601021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased sclerostin and preadipocyte factor-1 levels in prepubertal rhythmic gymnasts: associations with bone mineral density, body composition, and adipocytokine values.
    Jürimäe J; Tillmann V; Cicchella A; Stefanelli C; Võsoberg K; Tamm AL; Jürimäe T
    Osteoporos Int; 2016 Mar; 27(3):1239-1243. PubMed ID: 26323330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High levels of serum sclerostin and DKK1 in a case of Klippel-Trénaunay syndrome.
    Muto P; Lo Gullo A; Mandraffino G; Loddo S; Atteritano M
    Osteoporos Int; 2018 Jul; 29(7):1679-1681. PubMed ID: 29774401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.
    Amrein K; Amrein S; Drexler C; Dimai HP; Dobnig H; Pfeifer K; Tomaschitz A; Pieber TR; Fahrleitner-Pammer A
    J Clin Endocrinol Metab; 2012 Jan; 97(1):148-54. PubMed ID: 21994959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration.
    Voskaridou E; Christoulas D; Xirakia C; Varvagiannis K; Boutsikas G; Bilalis A; Kastritis E; Papatheodorou A; Terpos E
    Haematologica; 2009 May; 94(5):725-8. PubMed ID: 19407319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
    Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clearance of Sclerostin, Osteocalcin, Fibroblast Growth Factor 23, and Osteoprotegerin by Dialysis.
    Carlson N; Mortensen OH; Axelsen M; Pedersen RS; Heaf JG
    Blood Purif; 2017; 44(2):122-128. PubMed ID: 28554171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone.
    Idolazzi L; Fassio A; Tripi G; Braga V; Viapiana O; Adami G; Rossini M; Gatti D
    Clin Rheumatol; 2017 Apr; 36(4):925-928. PubMed ID: 28054306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.
    Morena M; Jaussent I; Dupuy AM; Bargnoux AS; Kuster N; Chenine L; Leray-Moragues H; Klouche K; Vernhet H; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2015 Aug; 30(8):1345-56. PubMed ID: 25854266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.
    Anastasilakis AD; Polyzos SA; Gkiomisi A; Bisbinas I; Gerou S; Makras P
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3206-12. PubMed ID: 23788684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5.
    Simpson CA; Foer D; Lee GS; Bihuniak J; Sun B; Sullivan R; Belsky J; Insogna KL
    Osteoporos Int; 2014 Oct; 25(10):2383-8. PubMed ID: 24927689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
    Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML
    Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negative impact of high cumulative glucocorticoid dose on bone metabolism of patients with myasthenia gravis.
    Braz NFT; Rocha NP; Vieira ÉLM; Gomez RS; Barbosa IG; Malheiro OB; Kakehasi AM; Teixeira AL
    Neurol Sci; 2017 Aug; 38(8):1405-1413. PubMed ID: 28488158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between sclerostin and Dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A prospective, cross-sectional study.
    Yang HY; Wu DA; Chen MC; Hsu BG
    Diab Vasc Dis Res; 2019 May; 16(3):281-288. PubMed ID: 30547685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients.
    Folestad A; Ålund M; Asteberg S; Fowelin J; Aurell Y; Göthlin J; Cassuto J
    Acta Orthop; 2015; 86(4):415-25. PubMed ID: 25811776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.